Investigating the Impact of SN-38 on Mouse Brain Metabolism Based on Metabolomics

References

• Yang J, Jia L, He Z. et al. Recent advances in SN-38 drug delivery system.Int. J Pharmaceut. 2023:637. 10.1016/j.ijpharm.2023.122886.
   PubMed Web of Science ®Google Scholar
• Qi Q, Tian H, Yue B, et al. Research progress of SN38 drug delivery system in cancer treatment. Int J Nanomed. 2024;19:945–964. doi:10.2147/IJN.S435407
   PubMed Web of Science ®Google Scholar
• Zhu X, Ni S, Xia T, et al. Anti-neoplastic cytotoxicity of SN-38-loaded PCL/Gelatin electrospun composite nanofiber scaffolds against human glioblastoma cells in vitro. J Pharm Sci. 2015;104(12):4345–4354. doi:10.1002/jps.24684
   PubMed Web of Science ®Google Scholar
• Bao X, Wu J, Kim S, et al. Pharmacometabolomics reveals irinotecan mechanism of action in cancer patients. J Clini Pharma. 2018;1(1):1–15. doi:10.1002/jcph.1275
   Google Scholar
• De Lisa M, Ballatore Z, Marcantognini G, et al. Irinotecan-induced transient dysarthria: case series and updated literature review. Oncol Ther. 2020;8(1):147–160. doi:10.1007/s40487-019-00106-z)
   PubMed Web of Science ®Google Scholar
• Gupta N, Vats S, Bhargava P. Sustainable agriculture: role of metagenomics and metabolomics in exploring the soil microbiota, in: silico Approach for Sustainable Agriculture. Springer. 2018;183–199. doi:10.1007/978-981-13-0347-0_11
   Google Scholar
• Shoaib M, Choudhary R, Choi J, et al. Plasma metabolomics supports the use of long-duration cardiac arrest rodent model to study human disease by demonstrating similar metabolic alterations. Sci Rep. 2020; 10(1): 19707. 10.1038/s41598-020-76401-x
   PubMed Web of Science ®Google Scholar
• Pang H, Jia W, Hu Z. Emerging applications of metabolomics in clinical pharmacology. Clin Pharmacol Ther. 2019;106(3):544–556. doi:10.1002/cpt.1538
   PubMed Web of Science ®Google Scholar
• Nobre LMS, da Silva Lopes MH, Geraix J, et al. Paraprobiotic Enterococcus faecalis EC-12 prevents the development of irinotecan-induced intestinal mucositis in mice. Life Sci. 2022;296:120445. doi:10.1016/j.lfs.2022.120445
   PubMed Web of Science ®Google Scholar
• Takeda M, Koseki J, Takahashi H, et al. Disruption of endolysosomal RAB5/7 efficiently eliminates colorectal cancer stem cells. Cancer Res. 2019;79(7):1426–1437. doi:10.1158/0008-5472.CAN-18-2192))
   PubMed Web of Science ®Google Scholar
• Viant MR, Kurland IJ, Jones MR, et al. How close are we to complete annotation of metabolomes?. Curr Opin Chem Biol. 2017;36:64–69. doi:10.1016/j.cbpa.2017.01.001
   PubMed Web of Science ®Google Scholar
• Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev. 2007;87(2):659–797. doi:10.1152/physrev.00043.2006
   PubMed Web of Science ®Google Scholar
• Muhleder S, Fuchs C, Basilio J, et al. Purinergic P2Y2 receptors modulate endothelial sprouting. Cell Mol Life Sci. 2020;77(5):885–901. doi:10.1007/s00018-019-03213-2
   PubMed Web of Science ®Google Scholar
• Burnstock G. Introduction to purinergic signalling in the brain. Adv Exp Med Biol. 1202;1–12. doi:10.1007/978-3-030-30651-9_1
   Google Scholar
• Burnstock G. Purinergic signalling and neurological diseases: An update. CNS Neurol Disord Drug Tar. 2017;16(3):257–265. doi:10.2174/1871527315666160922104848
   PubMed Web of Science ®Google Scholar
• Illes P, Xu GY, Tang Y. Purinergic signaling in the central nervous system in health and disease. Neurosci Bull. 2020;36(11):1239–1241. doi:10.1007/s12264-020-00602-7
   PubMed Web of Science ®Google Scholar
• Chen L, Li L, Zhou C, et al. Adenosine A2A receptor activation reduces brain metastasis via SDF-1/CXCR4 axis and protecting blood-brain barrier. Molecular Carcinogenesis. 2020;59(4):390–398. doi:10.1002/mc.23161 Mol. Carcinog.2020.
   PubMed Web of Science ®Google Scholar
• Wu ST, Han JR, Yao N, et al. Activation of P2X4 receptor exacerbates acute brain injury after intracerebral hemorrhage. CNS Neurosci Ther. 2022;28(7):1008–1018. doi:10.1111/cns.13831
   PubMed Web of Science ®Google Scholar
• Bourke CA. Astrocyte dysfunction following molybdenum associated purine loading could initiate Parkinson’s disease with dementia. NPJ Parkinsons Dis. 2018;4(1):7. doi:10.1038/s41531-018-0045-5
   PubMedGoogle Scholar
• Alonso‐Andrés P, Albasanz JL, Ferrer I, Martín M. Purine‐related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer’s disease pathology. Brain Pathol. 2018;28(6):933–946. doi:10.1111/bpa.12592
   PubMed Web of Science ®Google Scholar
• Su C, Elfeki N, Ballerini P, et al. Guanosine improves motor behavior, reduces apoptosis, and stimulates neurogenesis in rats with parkinsonism. J Neurosci Res. 2009;87(3):617–625. doi:10.1002/jnr.21883
   PubMed Web of Science ®Google Scholar
• Hansel G, Tonon AC, Guella F, et al. Guanosine protects against cortical focal ischemia. Involvement of inflammatory response. Mol Neurobiol. 2015;52(3):1791–1803. doi:10.1007/s12035-014-8978-0
   PubMed Web of Science ®Google Scholar
• Lanznaster D, Mack JM, Coelho V, et al. Guanosine prevents anhedonic-like behavior and impairment in hippocampal glutamate transport following amyloid-β1-40 administration in mice. Molecular Neurobiology. 2017;54(7):5482–5496. doi:10.1007/s12035-016-0082-1 Mol. Neurobiol.2017.
   PubMed Web of Science ®Google Scholar
• Schmidt AP, Tort AB, Souza DO, Lara DR. Guanosine and its modulatory effects on the glutamatergic system. Eur Neuropsycho. 2008;18(8):620–622. doi:10.1016/j.euroneuro.2008.01.007
   PubMed Web of Science ®Google Scholar
• Almeida RF, Comasseto DD, Ramos DB, et al. Guanosine anxiolytic-like effect involves adenosinergic and glutamatergic neurotransmitter systems. Mol Neurobiol. 2017;54(1):423–436. doi:10.1007/s12035-015-
   PubMed Web of Science ®Google Scholar
• Kovacs Z, Kekesi KA, Dobolyi A, Lakatos R, Juhasz G. Absence epileptic activity changing effects of non-adenosine nucleoside inosine, guanosine and uridine in Wistar Albino Glaxo Rijswijk rats. Neuroscience. 2015;300(0):593–608. doi:10.1016/jneuroscience.2015.05.054
   PubMedGoogle Scholar
• Razak M, Begum P, Viswanath B, et al. Multifarious beneficial effect of nonessential amino acid, Glycine: a review. Oxid Med Cell Longev. 2017;2017:1–8. doi:10.1155/2017/1716701
   Web of Science ®Google Scholar
• Jiang H, Zhang Y, Wang Z, et al. Connexin 43: an Interface Connecting neuroinflammation to Depression. Molecules. 2023;28(4). doi:10.3390/molecules28041820
   Web of Science ®Google Scholar
• Zhao S, Zhong H, Geng C, et al. Comprehensive analysis of metabolic changes in rats exposed to acrylamide. Environ Pollut. 2021;287(0): 117591. doi:10.16/j.envpol.2021.117591
   PubMedGoogle Scholar
• Faria M, Ziv T, Gómez-Canela C, et al. Acrylamide acute neurotoxicity in adult zebrafish. Sci Rep. 2018;8(1). doi:10.1038/s41598-018-26343-2
   Google Scholar
• Thomas G, Budd Samantha L, Lipton Stuart A. Excitatory amino acid neurotoxicity. Adv Exp Med Biol. 2002;513(undefined):3–40. doi:10.1007/978-1-4615-0123-7_1
   PubMedGoogle Scholar
• Norman JE, Nuthikattu S, Milenkovic D, et al. Sex modifies the impact of type 2 diabetes mellitus on the murine whole brain metabolome. Metabolites. 2023;13(9). doi:10.3390/metabo13091012
   PubMed Web of Science ®Google Scholar
• Lu L-H, Xia Z-X, Guo J-L, et al. Metabolomics analysis reveals perturbations of cerebrocortical metabolic pathways in the Pah enu2 mouse model of phenylketonuria. CNS Neurosci Ther. 2020;26(4):486–493. doi:10.1111/cns.13214
   PubMed Web of Science ®Google Scholar
• Zhang L, Wong LR, Wong P, et al. Chronic treatment with baicalein alleviates behavioural disorders and improves cerebral blood flow via reverting metabolic abnormalities in a J20 transgenic mouse model of Alzheimer’s disease. Brain, Behavior, & Immunity - Health. 2023;28. doi:10.1016/j.bbih.2023.100599
   PubMedGoogle Scholar
• Brosnan Margaret E, Brosnan John T. Histidine metabolism and function. J Nutr. 2020;150(Suppl 1):2570S–2575S. doi:10.1093/jn/nxaa079
   PubMedGoogle Scholar
• Ostfeld I, Hoffman JR. The effect of β-alanine supplementation on performance, cognitive function and resiliency in soldiers. Nutrients. 2023;15(4):1039. doi:10.3390/nu15041039
   PubMed Web of Science ®Google Scholar
• Meftahi GH, Jahromi GP. Biochemical mechanisms of beneficial effects of beta-alanine supplements on cognition. Biochemistry. 2023;88(8). doi:10.1134/S0006297923080114
   PubMed Web of Science ®Google Scholar
• Dejakaisaya H, Harutyunyan A, Kwan P, et al. Altered metabolic pathways in a transgenic mouse model suggest mechanistic role of amyloid precursor protein overexpression in Alzheimer’s disease. Metabolomics. 2021;17(5). doi:10.1007/s11306-021-01793-4.
   PubMed Web of Science ®Google Scholar
• Maria K, Luke W, Belinda B, Erickson Kirk I, Elaine H. Associations of the lipidome with ageing, cognitive decline and exercise behaviours. Metabolites. 2022;12(9):undefined. doi:10.3390/metabo12090822
   Web of Science ®Google Scholar
• Han B, Wang JH, Geng Y, Han B, Wang JH, Geng Y. Chronic stress contributes to cognitive dysfunction and hippocampal metabolic abnormalities in APP/PS1 mice. Cell Physiol Biochem. 2017;41(5):1766–1776. doi:10.1159/000471869
   PubMedGoogle Scholar
• Fonta C, Salles J-P. Salles JP,Neuromuscular features of hypophosphatasia. Arch Pediatr. 2017;24(5):5S85–5S88. doi:10.1016/S0929-693X(18)30021-6
   PubMed Web of Science ®Google Scholar
• Fanton S, Menezes J, Krock E, et al. Anti-satellite glia cell IgG antibodies in fibromyalgia patients are related to symptom severity and to metabolite concentrations in thalamus and rostral anterior cingulate cortex. Brain Behav Immun. 2023;116:114. doi:10.1016/j.bbi.2023.09.003
   PubMedGoogle Scholar
• Zhang X, Wu Q, Lu Y, et al. Cerebroprotection by salvianolic acid B after experimental subarachnoid hemorrhage occurs via Nrf2- and SIRT1-dependent pathways. Free Radic Biol Med. 2018;124(0):504–516. 10.1016/j.freeradbiomed.2018.06.035
   PubMedGoogle Scholar